Medtronic MDT
$101.80 −$3.04 (-2.90%)
Market closed · Nov 7, 9:40 pm ET · Last extended-hours $101.23 -0.56%
Open$101.54
Prev close$104.84
Day range$100.80 – $103.07
Volume7.45M
Market cap$130.22B
P/E (TTM)25.1
Dividend yield2.80%
Earnings
Average move on report day±3.6%last 16 reports
Closed higher7 of 1644% of the time
Best reaction+5.7%
Worst reaction-7.3%
Stock move on the day after each report
| Quarter | Report date | Timing | Implied move | Actual move | Versus implied |
|---|---|---|---|---|---|
| 2027/Q1 | 1 Sep 2026 | Pre Market | ±4.9% | +1.53% | Within range |
| 2026/Q4 | 3 Jun 2026 | Pre Market | ±4.6% | +5.69% | Bigger than priced |
| 2026/Q3 | 17 Feb 2026 | Pre Market | ±4.5% | -3.10% | Within range |
| 2025/Q4 | 21 May 2025 | Pre Market | ±4.3% | -2.27% | Within range |
| 2025/Q3 | 18 Feb 2025 | Pre Market | ±3.7% | -7.26% | Bigger than priced |
| 2025/Q2 | 19 Nov 2024 | Pre Market | ±3.8% | -2.96% | Within range |
| 2025/Q1 | 20 Aug 2024 | Pre Market | ±3.9% | +0.66% | Within range |
| 2024/Q4 | 23 May 2024 | Pre Market | ±4.2% | -5.11% | Bigger than priced |
| 2024/Q3 | 20 Feb 2024 | Pre Market | ±4.3% | +1.69% | Within range |
| 2024/Q2 | 21 Nov 2023 | Pre Market | ±3.9% | +4.60% | Bigger than priced |
| 2024/Q1 | 22 Aug 2023 | Pre Market | ±4.2% | +2.59% | Within range |
| 2023/Q4 | 25 May 2023 | None | ±3.6% | -4.51% | Bigger than priced |
| 2023/Q3 | 21 Feb 2023 | Pre Market | ±4.3% | +0.81% | Within range |
| 2023/Q2 | 22 Nov 2022 | Pre Market | ±3.8% | -5.30% | Bigger than priced |
| 2023/Q1 | 23 Aug 2022 | Pre Market | ±3.8% | -3.08% | Within range |
| 2022/Q4 | 26 May 2022 | None | ±3.8% | -5.78% | Bigger than priced |
"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.
Where the revenue comes from
Quarter 2027/Q1
By business line
Fundamentals
Latest reported quarter: Q1, ended Jul 2026
Revenue$9.76B+13.7% YoY
Operating profit$1.84B+21.1% YoY
Net profit$1.48B+41.3% YoY
Diluted EPS$1.14+40.7% YoY
Free cash flow$1.29B+120.9% YoY
Operating cash flow$1.79B
Revenue, last 8 quarters
Net profit, last 8 quarters
Profitability & balance sheet
Gross margin65.0%
Operating margin19.0%
Net margin13.9%
Return on equity10.7%
Return on assets5.7%
Return on invested capital7.5%
Current ratio2.07
Liabilities / assets45.5%
Cash & investments$8.82B
Total debt$28.15B
Net cash (debt)-$19.33B
Free cash flow / sales16.3%
No comments yet — be the first to weigh in on MDT.
Sign in to join the discussion.